Investing, Biotechnology, Venture Capital, Science, Immune System.
(TAAs). However, these efforts were largely unsuccessful due to the minimal solid tumor antigen present in circulation, leading to biodistribution being dominated by the cytokine itself. To address this issue, newer immunocytokine designs utilize affinity-weakened cytokines, where productive